Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy

Journal of Clinical Oncology

Volumn 16, Issue 9, 1998, Pages 3094-3100

  D'Amico, Anthony V ^a   Whittington, Richard ^b   Malkowicz, S Bruce ^b   Schultz, Delray ^b   Kaplan, Irving ^b   Beard, Clair J ^b   Tomaszewski, John E ^b   Renshaw, Andrew A ^b   Loughlin, Kevin R ^b   Richie, Jerome P ^b   Wein, Alan ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; VALIDATION PROCESS;

EID: 0031671257     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.9.3094     Document Type: Article

References (30)

1. Smith D, Catalona WJ: The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 152:1732-1735, 1994
2. Culp OS: Radical perineal prostatectomy: its past, present, and possible future. J Urol 98:625-635, 1968
3. Jewett HJ, Eggleston JC, Yawn DH: Radical prostatectomy in the management of carcinoma of the prostate: Probable causes of some therapeutic failures. J Urol 107:1034-1040, 1972
4. Benson RC Jr, Tomera KM, Zincke H, et al: Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma confined to the prostate. J Urol 131:1103-1107, 1984
5. Blute ML, Nativ O, Zincke H, et al: Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy. J Urol 142:1262-1265, 1989
6. Walsh PC, Partin AW, Epstein JI: Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J Urol 152:1831-1836, 1994
7. Partin AW, Kattan MW, Subong ENP, et al: Combination of prostate specific antigen, clinical stage, and gleason score to predict pathologic stage of localized prostate cancer: A multi-institutional update. JAMA 277:1445-1451, 1997
8. Partin AW, Piantadosi S, Sanda MG, et al: Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology 45:831-838, 1995
9. Lerner SE, Blute ML, Bergstralh EJ, et al: Analysis of risk factors for progression in patients with pathologically organ confined prostate cancers after radical retropubic prostatectomy. J Urol 156:137-143, 1996
10. Zietman AL, Edelstein RA, Coen JJ, et al: Radical prostatectomy for adenocarcinoma of the prostate. The influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43:828-833, 1994
11. D'Amico AV, Whittington R, Malkowicz SB, et al: PSA failure despite pathologically organ confined and margin negative disease: The basis for an adjuvant therapy trial. J Clin Oncol 15:1465-1469, 1997
12. Kupelian P, Katcher J, Levin HS, et al: Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys 37:1043-1052, 1997
13. D'Amico AV, Whittington R, Kaplan I, et al : Equivalent biochemical failure free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. Int J Radiat Oncol Biol Phys 37:1053-1058, 1997
14. Zagars GK, Pollack A, Kavadi VS, et al: Prostate specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 32:293-306, 1995
15. Pisansky TM, Kahn MJ, Rasp GM, et al: A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate cancer. Cancer 79:337-344, 1997
16. Lee WR, Hanks GE, Schultheiss TE, et al: Localized prostate cancer treated by external beam radiotherapy alone: Serum prostate specific antigen driven outcome analysis. J Clin Oncol 13:464-469, 1995
17. Pisansky TM, Cha SS, Earle JD, et al: Prostate specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer. J Clin Oncol 11:2158-2166, 1993
18. Hanks GE, Lee WR, Schultheiss TE: Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. J Urol 154:456-459, 1995
19. D'Amico AV, Whittington R, Malkowicz SB, et al: Outcome based staging for clinically localized adenocarcinoma of the prostate. J Urol 158:1422-1426, 1997
20. D'Amico AV, Whittington R, Malkowicz SB, et al: Calculated prostate carcinoma volume: The optimal predictor of 3-year bNED survival after radical prostatectomy or external beam radiation therapy. Cancer 82:334-341, 1998
21. Gleason DF, Veterans Administration Cooperative Urological Research Group: Histologic grading and staging of prostatic carcinoma, in Tannenbaum M (ed): Urologic Pathology. Philadelphia, PA, Lea & Febiger, 1977, pp 171-187
22. Beahrs OH, Henson DE, Hutter RVP: American Joint Committee on Cancer, Manual for Staging Cancer (ed 4). Philadelphia, PA, Lippincott, 1992
23. Oesterling JE, Jacobsen SJ, Klee GG, et al: Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090-1095, 1995
24. Epstein JI, Pizov G, Walsh PC: Correlation of pathologic findings with progression after radical prostatectomy. Cancer 71:3582-3593, 1993
25. Cox DR: Regression models and life tables. J Roy Stat Soc B 34:187-189, 1972
26. Cox JD: Consensus Statement: Guidelines for PSA Following Radiation Therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
27. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. JAMA 53:457-500, 1958
28. Liebel SA, Zelefsky MJ, Kutcher GJ, et al: The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin Oncol 21:580-597, 1994
29. Movsas B, Hanlon A, Teshima T, et al: Analyzing predictive models following definitive radiotherapy for prostate cancer. Cancer 80:1093-1102, 1997
30. D'Amico AV, Desjardin A, Chen M-H, et al: Assessment of outcome prediction models for localized prostate cancer in patients managed with radical prostatectomy or external beam radiation therapy. Cancer 82:1887-1896, 1998